Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | VIVIMEDLAB Vivimed Labs Limited Pharma · Small | MANGALAM Mangalam Drugs And Organics Limited Pharma · Small | NATCAPSUQ Natural Capsules Limited Pharma · Small | MAXHEALTH Max Healthcare Institute Limited Pharma · Large |
|---|---|---|---|---|
| Final Score | 10 | 2 | 17 | 35 |
| Verdict | OVERVALUED | OVERVALUED | OVERVALUED | WATCHLIST |
| Style | OVERVALUED | Distress Watch | OVERVALUED | WATCHLIST |
| Piotroski | 3/9 | 3/9 | 6/9 | 8/9 |
| Valuation | 2/30 | 5/30 | 5/30 | 0/30 |
| Growth | 7/25 | 1/25 | 7/25 | 19/25 |
| Quality | 0/20 | 0/20 | 0/20 | 2/20 |
| Balance Sheet | 4/15 | 1/15 | 7/15 | 5/15 |
| Cash Flow | 3/10 | 1/10 | 2/10 | 4/10 |
| Price | ₹6.15 | ₹28.33 | ₹158.85 | ₹1,003 |
| P/E | — | — | — | 67.50 |
| P/B | — | 0.44 | 0.70 | 9.83 |
| ROE | — | -35.20% | -7.30% | 12.70% |
| ROCE | -8.10% | -14.30% | -4.76% | 14.90% |
| Debt / Equity | 0.00 | 1.02 | 0.49 | 0.33 |
| FCF Yield | — | — | — | — |
| Dividend Y | — | — | — | 0.15% |
| Altman Z | -0.03 | 1.21 | 1.88 | 0.00 |
| Promoter % | 7.57% | 35.65% | 51.04% | 23.71% |
| Mkt Cap (₹Cr) | 51.70 | 45.00 | 164.00 | — |
| Graham # | — | — | — | ₹84.62 |
| Fair PE | 45.0 | 1.9 | 10.7 | 42.0 |
| MoS % | — | — | — | -672.9% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startVIVIMEDLAB24
MANGALAM26
NATCAPSUQ64
MAXHEALTH93